Sales rise 2.17% to Rs 4.23 crore
Net profit of Beryl Drugs rose 70.00% to Rs 0.34 crore in the quarter ended June 2019 as against Rs 0.20 crore during the previous quarter ended June 2018. Sales rose 2.17% to Rs 4.23 crore in the quarter ended June 2019 as against Rs 4.14 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales4.234.14 2 OPM %13.719.42 -PBDT0.480.35 37 PBT0.380.25 52 NP0.340.20 70Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
